Displaying items by tag: pharmaceuticals
The Institute for Microbial Biotechnology and Metagenomics (IMBM) is a leading research unit based within the Department of Biotechnology at the University of the Western Cape (UWC). Our research employs culture-based approaches as well as cutting edge ”omics” strategies to study microbiomes and identify novel biosynthetic gene clusters and metabolites. The Institute focuses on the research and development of novel, high - value natural products for the pharmaceutical, cosmeceutical, food and beverage and agricultural industries, as well as products for industrial processes.
MSc and PhD POSITIONS AVAILABLE
1. Expression and characterization of an endolysin from a novel Paenibacillus larvae phage, and its assessment as a phage therapy against AFB disease which affects the Western Cape honeybee, in collaboration with the ARC Infruitec-Nietvoorbij.
2. Genome sequence analysis of a marine isolates that produce potent activity against the ESKAPE pathogens, in collaboration with academic and industry partners.
3. Characterisation of anti-cancer activity produced by a marine isolate: a genomic and chemical approach, in collaboration with MEDINA (Spain).
4. The investigation of bacteriophages associated with Chryseobacterium and their potential in combating food spoilage. Novel enzymes and compounds produced by Chryseobacterium will also be investigated.
BSc Hons, MSc, or an equivalent qualification, with a minimum average score of 60% and a major in either Microbiology, Biotechnology, Biochemistry or Genetics. Only South African citizens can be considered.
Experience and skill in molecular biology techniques; responsibility, reliability, good problem solving, time management, communication (written and verbal) and interpersonal skills, as well as computer literacy are absolute requirements.
THE CLOSING DATE FOR APPLICATIONS IS 9 January 2019.